The bacteriophage market is capturing a valuation of US$ 45.07 million in 2023 and is predicted to reach US$ 68 million by 2033. The market is likely to register a CAGR of 4.2% during the forecast period.
The demand for bacteriophages is increasing due to their dietary supplement use. Its adoption reduces the risk of incidence of food born infections. These dietary supplements contain a specific combination of bacteriophages that attacks particular organisms in the gut.
Phage therapeutics can be used to treat and prevent antibiotic resistance infections, urinary tract infections, dysentery, and others. The rising demand for personalized medicine and advanced phage therapy research is fueling the market growth.
The rising bacterial infection due to the aging population, climate change, and global travel are increasing the adoption of bacteriophage. Public and private companies' rising investment in the phage therapy sector enhances market opportunities. Through research and development activities, they are carryout better phage-based treatments.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 4.2% |
| Market Valuation (2023) | US$ 45.07 million |
| Market Valuation (2033) | US$ 68 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Several factors decline the growth of the market are:
The high cost of bacteriophage treatment is a leading factor limiting the market growth. Due to the high cost of therapy, several healthcare facilities, such as small hospitals & clinics, cannot afford the treatment. In underdeveloped areas, the lack of facilities and treatment also leads to a decline in the demand for bacteriophage.
Low and middle-income countries generate more revenue from antibiotics as compared to bacteriophage. They require cheaper and show immediate results are slow down the market growth in these countries.
The changing consumer preferences for alternative treatment, lack of new innovative treatments, and economic downfall are restraining the market growth.
Growing research and development of drugs and therapies for infectious diseases is expected to create immense market opportunities. Rising interest in developing drugs such as infectious diseases and immunological disorders boosts the market.
For instance, in June 2020, Microgen opened a Biological Research Center to study bacteriophages. The main purpose of this center is to improve the treatment and prevention of drugs being an alternative to antibiotics.
According to research by the World Health Organization, antibiotic-resistant infections could kill about 10 million people yearly by 2050. There is a huge unmet need in patients with bacterial infections. These are mostly very difficult to treat with traditional antibiotic therapy.
For instance, In October 2021, Intralytix, Inc. received clearance from the United States Food and Drug Administration for an Investigational New Drug (IND) application for its product ShigActive.
Principal Consultant
According to Future Market Insights, the overall bacteriophage sales were valued at around US$ 43.2 million in 2022.
The human gut is easily prone to attack by bacteriophages. As bacteriophages are bacteria eaters, they can easily affect the gut microbiota population and, in turn, influence gene expression patterns in microbes.
The consumption of phage probiotics promotes good bacteria over bad bacteria and maintains a good balance. It promotes a healthy lifestyle among individuals. For instance, In June 2021, Life Extension launched a new formula for supporting bowel regularity, FLORASSIST Daily Bowel Regularity.
The probiotic strain has been shown to maintain bowel regularity and defend against occasional constipation. A slew of such developments by key players is expected to boost the market. The rising prevalence of antibiotic resistance and limited discoveries for new antibiotics propel the market growth.
It has shifted the focus of healthcare professionals in developed countries toward research and development. It is projected to improve the demand in the bacteriophage market, replacing traditional probiotics.
For instance, in January 2020, Life Extension developed a novel approach for supporting healthy liver, FLORASSIST Liver Restore. This daily, synbiotic proprietary blend combines clinically-studied PRObiotic bacteria with PRE-biotic that helps those strains thrive in the gut.
Based on product type, the phage probiotics segment is securing a share of 95.39% in the global market. The growth of this product is associated with its ability to improve gut flora diversity and promote the growth of good bacteria. The rising demand for natural alternatives and growing awareness is increasing the adoption of phage probiotics.
Preference for Non-invasive Treatment to Increase the Demand for Oral Route of Administration in the Market
Oral route of administration benefits the most as they have more than 96% share in revenue and is expected to record a CAGR of 4.3% in the forecast period. It is a highly preferred route of administration since it is self-administrable, non-invasive, and cost-effective.
Demand for Bacteriophage Formulations in Gastroenterology to Increase
Based on application, the gastroenterology segment is anticipated to capture a share of 94% during the forecast period. Bacteriophages are used as dietary supplements to improve gut health.
Bacteriophages are still not approved by United States FDA as a treatment option for many antibiotic-resistant infections in many regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | Projected Share |
|---|---|
| United States | 26.3% |
| Germany | 4.4% |
| Japan | 3.1% |
| Australia | 5.0% |
| China | 6.80% |
| India | 5.40% |
| United Kingdom | 3.20% |
The United States is estimated to dominate the global market by capturing a share of 26.3% during the forecast period. The bacteriophage is an entry-level state in the country. The rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country.
Several institutions are investing in research and development activities to improve phage therapy. Various companies in the United States are treating bacterial infections in animals, humans, agricultural use, and food safety. The key companies in the United States bacteriophage market are PhagePro, AmpliPhi Biosciences, Intralytix, and Adaptive Phage Therapeutics.
Germany is significantly growing the global market by registering a share of 4.4% during the forecast period. The increasing demand for treating infectious bacteria is growing German market. The country is growing with favorable regulatory policies and less stringent rules for approving bacteriophage formulations.
Institutes are developing products such as drugs and medicine for several industries. They adopt new treatments and therapies through their research and developments, surging the market size. The rising clinical settings for bacteriophage are estimated to fuel the market size in the country.
Australia to Emerge as a Lucrative Market in Oceania
Sales of bacteriophage in Australia are projected to increase by 5% during the forecast period. The country is attributed to the rising wave of advancements in phage therapy strategies in Oceania.
Australia is one of the significant countries with market potential growth. The increasing patient demand for antibiotic infections is rising the medical products in the country. The rising various institutional and academic research are performing their role to enhance the market size.
India Bacteriophage Market to Spearhead the Growth in South Asia
During the forecast period, India is anticipated to secure a share of 5.40% in the global market. Demand for bacteriophage is witnessing a rapid increase in antibacterial-resistant infections in India.
Key companies in India are collaborating and extending their partnerships with pre-existing giants to expand their product portfolio. It is expected to facilitate growth in the market. The rapidly growing clinics and hospitals in the use of bacteriophage fueling the Indian market.
The manufacturers are expanding the global market in several ways are:
Leading bacteriophage manufacturers are focusing on geographical expansion to increase their revenue & expand their footprint. These players are innovating to improve products that desire end-users requirements. These essential players are adopting various marketing strategies to upsurge the market to another height.
The marketing methodologies are strategic collaborations, acquisitions, expansion, product launches, agreements, and research sponsorship. The key strategies adopted by manufacturers to increase product sales in different geographies.
Other Prominent Players in the Global Market are:
Recent Developments in the Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product Type, Application, Route of Administration, Distribution Channel, Region |
| Key Companies Profiled | Life extension; Arthur Andrew Medical; Deerland Probiotics & Enzymes Inc.; BioChimpharm; Micreos Human Health; Designs for Health; Accelerated Health Systems LLC; The biostation; Microgen; IntraLytix Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The gas steam segment leads and could exhibit a 2.5% CAGR through 2033.
The overall industry value could reach almost US$ 68 million by 2033.
The global demand for bacteriophage is expected to rise at merely 4.2% CAGR through 2033.
The United States market held 26.3% market share in 2022.
The phage probiotics segment is highly popular with 95.39% market share in 2022.
1. Executive Summary | Bacteriophage Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Phage Probiotics 5.3.2. Phage Therapeutics 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033 6.3.1. Oral 6.3.2. Topical 6.3.3. Others 6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033 7.3.1. Gastroenterology 7.3.2. Respiratory infections 7.3.3. Skin infection treatment 7.3.4. Wound prophylaxis 7.3.5. Urogenital infection treatment 7.3.6. Others 7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 8.3.1. Retail 8.3.2. Hospital 8.3.3. Online 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Product 10.2.3. By Route of Administration 10.2.4. By Application 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Route of Administration 10.3.4. By Application 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product 11.2.3. By Route of Administration 11.2.4. By Application 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Route of Administration 11.3.4. By Application 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product 12.2.3. By Route of Administration 12.2.4. By Application 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Route of Administration 12.3.4. By Application 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Product 13.2.3. By Route of Administration 13.2.4. By Application 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Route of Administration 13.3.4. By Application 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Route of Administration 14.2.4. By Application 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Route of Administration 14.3.4. By Application 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Product 15.2.3. By Route of Administration 15.2.4. By Application 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Route of Administration 15.3.4. By Application 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product 16.2.3. By Route of Administration 16.2.4. By Application 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Route of Administration 16.3.4. By Application 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product 17.1.2.2. By Route of Administration 17.1.2.3. By Application 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product 17.2.2.2. By Route of Administration 17.2.2.3. By Application 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product 17.3.2.2. By Route of Administration 17.3.2.3. By Application 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product 17.4.2.2. By Route of Administration 17.4.2.3. By Application 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product 17.5.2.2. By Route of Administration 17.5.2.3. By Application 17.5.2.4. By Distribution Channel 17.6. United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product 17.6.2.2. By Route of Administration 17.6.2.3. By Application 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product 17.7.2.2. By Route of Administration 17.7.2.3. By Application 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product 17.8.2.2. By Route of Administration 17.8.2.3. By Application 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product 17.9.2.2. By Route of Administration 17.9.2.3. By Application 17.9.2.4. By Distribution Channel 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product 17.10.2.2. By Route of Administration 17.10.2.3. By Application 17.10.2.4. By Distribution Channel 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product 17.11.2.2. By Route of Administration 17.11.2.3. By Application 17.11.2.4. By Distribution Channel 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product 17.12.2.2. By Route of Administration 17.12.2.3. By Application 17.12.2.4. By Distribution Channel 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product 17.13.2.2. By Route of Administration 17.13.2.3. By Application 17.13.2.4. By Distribution Channel 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product 17.14.2.2. By Route of Administration 17.14.2.3. By Application 17.14.2.4. By Distribution Channel 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product 17.15.2.2. By Route of Administration 17.15.2.3. By Application 17.15.2.4. By Distribution Channel 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product 17.16.2.2. By Route of Administration 17.16.2.3. By Application 17.16.2.4. By Distribution Channel 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product 17.17.2.2. By Route of Administration 17.17.2.3. By Application 17.17.2.4. By Distribution Channel 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product 17.18.2.2. By Route of Administration 17.18.2.3. By Application 17.18.2.4. By Distribution Channel 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product 17.19.2.2. By Route of Administration 17.19.2.3. By Application 17.19.2.4. By Distribution Channel 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product 17.20.2.2. By Route of Administration 17.20.2.3. By Application 17.20.2.4. By Distribution Channel 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product 17.21.2.2. By Route of Administration 17.21.2.3. By Application 17.21.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product 18.3.3. By Route of Administration 18.3.4. By Application 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Life extension 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Arthur Andrew Medical 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Deerland Probiotics & Enzymes Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. BioChimpharm 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Micreos Human Health 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Designs for Health 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Accelerated Health Systems LLC 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. The biostation 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Microgen 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. IntraLytix Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Bacteriophage Market
